21
22
23
enthalten in:
The Lancet. Respiratory medicine
| 2022
von
ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group
|
Ginde, A.
|
Paredes, R.
|
+98
24
25
26
27
28
29
30